User profiles for N. Weis

Nina Weis

- Verified email at dadlnet.dk - Cited by 10738

Nathan O Weiss

- Verified email at ucla.edu - Cited by 7439

Historical epidemiology of hepatitis C virus (HCV) in selected countries

…, W Vogel, I Waked, H Wedemeyer, N Weis… - Journal of viral …, 2014 - Wiley Online Library
Chronic infection with hepatitis C virus (HCV) is a leading indicator for liver disease. New
treatment options are becoming available, and there is a need to characterize the …

Potential for conflict of interest in the evaluation of suspected adverse drug reactions: use of cerivastatin and risk of rhabdomyolysis

BM Psaty, CD Furberg, WA Ray, NS Weiss - Jama, 2004 - jamanetwork.com
… On January 14, 2003, Dr Weiss received a letter that confirmed his agreement to serve as
an expert for plaintiffs in the Baycol Products Liability Litigation, MDL No. 1431, in the US …

Van der Waals heterostructures and devices

Y Liu, NO Weiss, X Duan, HC Cheng, Y Huang… - Nature Reviews …, 2016 - nature.com
… In conventional p–n junctions, the p- and n-type regions are formed by chemically doping
bulk semiconductors, generating built-in potentials inside the depletion zone (typically 10–100 …

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

…, D Vandijck, H Wedemeyer, N Weis… - Journal of viral …, 2014 - Wiley Online Library
The disease burden of hepatitis C virus ( HCV ) is expected to increase as the infected population
ages. A modelling approach was used to estimate the total number of viremic infections…

Antibacterial and antifungal properties of essential oil components

…, A Pauli, B Iberl, H Weigand, N Weis - Journal of essential oil …, 1989 - Taylor & Francis
The solubility in water of essential oil constituents is directly related to their ability to penetrate
the cell walls of a bacterium or fungus. The antimicrobial activity of essential oils is due to …

Circulating levels of TNF-alpha and IL-6-relation to truncal fat mass and muscle mass in healthy elderly individuals and in patients with type-2 diabetes

M Pedersen, H Bruunsgaard, N Weis… - Mechanisms of ageing …, 2003 - Elsevier
… Treatment of patients was diet alone (n=2) or oral hypoglycaemic agents; sulfonylurea (n=7),
metformine (n=1), meglitinide (n=1) or a combination of sulfonylurea and metformine (n=5). …

Efficacy and safety of 8 weeks versus 12 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin in patients with hepatitis C …

…, J Mallolas, S Pol, M Kugelmas, A Murillo, N Weis… - The Lancet, 2015 - thelancet.com
Background Both hepatitis C virus (HCV) mono-infected and HIV/HCV co-infected patients
are in need of safe, effective, all-oral HCV regimens. In a phase 2 study we aimed to assess …

Strategies to manage hepatitis C virus (HCV) disease burden

…, D Vandijck, W Vogel, I Waked, N Weis… - Journal of viral …, 2014 - Wiley Online Library
The number of hepatitis C virus ( HCV ) infections is projected to decline while those with
advanced liver disease will increase. A modeling approach was used to forecast two treatment …

Taxonomic study of Weissella confusa and description of Weissella cibaria sp. nov., detected in food and clinical samples.

…, U Schillinger, R Geisen, N Weiss… - … of Systematic and …, 2002 - microbiologyresearch.org
… strains of their closest phylogenetic neighbour, Weisella confusa. The DNA GjC content
of Weisella cibaria strains LMG 17699T, LMG 17706, LMG 18506, LMG 18507, LMG 18814 …

[HTML][HTML] HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients

SL Seliger, NS Weiss, DL Gillen, B Kestenbaum… - Kidney international, 2002 - Elsevier
HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients.
Background Patients with end-stage renal disease (ESRD) suffer from markedly higher rates of …